SelectScience InterviewsLife Sciences
Why glycosylation is the missing piece in cancer research
13 May 2026
Discover how glycobiology is transforming cancer research by revealing critical glycosylation patterns invisible to traditional proteomics. In this SelectScience interview, Erika Leonard, Director of R&D at Vector Laboratories , explains how validated lectins and advanced glycan‑binding tools bring spatial insight, reproducibility, and confidence to multiomic workflows, helping researchers better understand the tumor microenvironment and advance therapeutic discovery.
This video was filmed at AACR Annual Meeting 2026.
Related Products
Request Quote for All Products
Glycobiology Reagents
Vector Laboratories Inc.Founded on a growing portfolio of purified lectins, lectin conjugates, and lectin screening kits, Vector Laboratories supports the ability to profile, characterize, and capture complex glycans in biological systems.
